67967-11-7

Usage

Uses

Used in Pharmaceutical Industry:
7H-1,7-NAPHTHYRIDIN-8-ONE is used as a chemical intermediate for the synthesis of various drugs. Its unique structure and properties make it a valuable component in the development of new pharmaceutical compounds.
Used in Biological Research:
7H-1,7-NAPHTHYRIDIN-8-ONE is used as a fluorescent dye in biological imaging applications. Its fluorescent properties allow researchers to visualize and study cellular processes and structures with greater precision.
Used in Anti-Inflammatory Applications:
7H-1,7-NAPHTHYRIDIN-8-ONE has been studied for its potential anti-inflammatory properties. It may be used as a therapeutic agent to alleviate inflammation and related symptoms in various medical conditions.
Used in Antimicrobial Applications:
7H-1,7-NAPHTHYRIDIN-8-ONE has also been investigated for its antimicrobial properties. It may be utilized as an antimicrobial agent to combat bacterial infections and promote overall health.

InChI:InChI=1/C8H6N2O/c11-8-7-6(3-5-10-8)2-1-4-9-7/h1-5H,(H,10,11)

Upstream product

• 33630-99-8 2-hydroxy-3-aminopyridine 
• 7732-18-5 water 
• 56-81-5 glycerol 
• 98-47-5 3-Nitrobenzenesulfonic acid 
• 452-58-4 2,3-Diaminopyridine 
• 17965-82-1 8-amino-1,7-naphthyridine 
• 827616-52-4 2-cyano-3-iodopyridine 
• 97308-53-7 3-(2,2-Dimethoxy-ethyl)-pyridine-2-carbonitrile 
• 97308-50-4 3-Trimethylsilanylethynyl-pyridine-2-carbonitrile 
• 55758-02-6 3-bromopyridine-2-carbonitrile 
• 97308-57-1 3-(2,2-Dimethoxy-ethyl)-pyridine-2-carboxylic acid amide 

Downstream Products

• 1133854-40-6 7-benzyl-1,7-naphthyridin-8(7H)-one 
• 13058-77-0 8-chloro-[1,7]naphthyridine 
• 67967-14-0 5-bromo-7,8-dihydro-1,7-naphthyridin-8-one 

Relevant academic research and scientific papers

Synthesis of Isoquinolones by Sequential Suzuki Coupling of 2-Halobenzonitriles with Vinyl Boronate Followed by Cyclization

A novel, facile, and expeditious two-step synthesis of 3,4-unsubstituted isoquinolin-1(2H)-ones from a Suzuki cross-coupling between 2-halobenzonitriles and commercially available vinyl boronates followed by platinum-catalyzed nitrile hydrolysis and cyclization is described.

1-SUBSTITUTED 1,2,3,4-TETRAHYDRO-1,7-NAPHTHYRIDIN-8-AMINE DERIVATIVES AND THEIR USE AS EP4 RECEPTOR ANTAGONISTS

The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof has an EP4 receptor antagonistic action, and is useful as an agent for the prophylaxis or treatment of EP4 receptor associated diseases (e.g., rheumatoid arthritis, aortic aneurysm (e.g. abdominal aortic aneurysm, thoracic aortic aneurysm, thoracoabdominal aortic aneurysm etc.), endometriosis, ankylosing spondylitis, inflammatory breast cancer etc.) and the like.

Vanilloid receptor ligands and their use in treatments

Bicyclic 3,4-fused piperidine compounds, and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotizing agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.

Condensed Heteroaromatic Ring Systems. III. Synthesis of Naphthyridine Derivatives by Cyclization of Ethynylpyridinecarboxamides

Four kinds of naphthyridinones, i.e. 1,6-naphthyridin-5-one, 1,7-naphthyridin-8-one, 2,6-naphthyridin-2-one, and 2,7-naphthyridin-1-one derivatives, were commonly synthesized by the intramolecular cyclization of pyridinecarboxamides having an ethynyl group or β,β-dimethoxyethyl group adjacent to the carbamoyl group.The syntheses of the starting pyridine derivatives were easily accomplished by cross-coupling of the corresponding halopyridines with acetylenes.Keywords-intramolecular cyclization; palladium catalyst; trimethylsilylacetylene; naphthyridinone; pyridineacetaldehyde; 1(2H)-isoquinolone

NOVEL NAPHTHYRIDINES

Novel naphthyridines having a 3-amino-2-OR-propoxy substituent are disclosed. The compounds have β-adrenergic blocking and immediate onset antihypertensive activities.